arXiv ScienceSearch

arXiv subjects

Jianduo Zhao

Publications and source records attributed to Jianduo Zhao.

2 recordsLinked to original sources

Towards AI-Driven Nanomedicine Discovery: A Benchmark and Multimodal Learning Framework for Nano Self-Assembly Prediction

Nano self-assembly organizes molecular components into bioactive nanoscale structures. Self-assembled nanoparticles (NAPs) derived from Chinese herbal formulas and applications such as anti-lung-cancer therapy demonstrate the substantial potential of self-assembly for nanomedicine discovery. Yet discovery still relies on costly wet-lab screening, while existing machine learning approaches lack standardized tasks, effective pairwise compatibility modeling, and public benchmarks with unified evaluation. To address these limitations, we formalize NSA prediction as a binary classification task for predicting self-assembly between molecular pairs and then establish NSA-Bench, the first public benchmark with curated molecular combinations, experimental conditions, self-assembly labels, and standardized evaluation protocols. We further develop NSA-Net, an interaction-aware multimodal framework that integrates complementary molecular evidence from graph topology, sequence semantics, and physicochemical descriptors to learn molecular-pair representations for self-assembly prediction. Extensive experiments on NSA-Bench show that NSA-Net achieves a ROC-AUC of $0.9470\pm0.0112$ (Small) and $0.9492\pm0.0062$ (Large). On the Small track, it surpasses the strongest machine-learning and graph-based baselines by 3.9 and 17.1 percentage points, respectively. Representation analyses reveal interpretable molecular characteristics associated with self-assembly prediction captured by the learned representations. Moreover, an NSA-Agent case study further demonstrates how NSA-Net predictions can support formulation refinement through experimental-condition-aware reasoning. Our code is available at https://github.com/developer-hq/NSA-Net.

q-bio.QM

ProbeMatchDTI: Probe-Driven Multi-Scale Biochemical Pattern Matching for Drug-Target Interaction Prediction

Drug-target interaction (DTI) prediction is an important task in AI-driven drug discovery. Although recent biochemical representation learning methods have improved DTI prediction, their passive feature aggregation tends to favor dominant molecular patterns while suppressing weak yet binding-relevant signals, such as functional groups and residue-context patterns, limiting the modeling of multi-scale biochemical correspondences. To address this issue, we propose ProbeMatchDTI, a pattern-probe-driven framework comprising IterProbe and BindingProbe. IterProbe explicitly retains contextual states across refinement depths and uses learnable probes to select them at each position before cross-entity matching, thereby preserving weak biochemical patterns and strengthening associations among functional groups, local motifs, and molecular scaffolds. BindingProbe then characterizes cross-entity drug-protein complementarity at local biochemical-unit and whole-pair levels, jointly modeling fine-grained interactions and multi-scale correspondences while preserving weaker binding-relevant associations. Extensive experiments demonstrate the superiority of ProbeMatchDTI, achieving 2.0% and 0.5% higher AUC-ROC on BindingDB and DrugBank, respectively. Feature-level pattern analyses further characterize its probe-driven behavior in cross-scale biochemical pattern matching. We further connect ProbeMatchDTI predictions with an evidence-guided downstream drug-discovery workflow, demonstrating their utility for candidate refinement and validation planning. Our code is available at https://github.com/developer-hq/ProbeMatchDTI

cs.LG